226 related articles for article (PubMed ID: 16736689)
1. [Scientific evidence--applied in routine general practice. Successful decrease in pressure and risk].
MMW Fortschr Med; 2006 May; 148(18):42-3. PubMed ID: 16736689
[No Abstract] [Full Text] [Related]
2. [Successful mega studies with heart patients. Valsartan possesses cardioprotective action].
MMW Fortschr Med; 2006 Feb; 148(5):48-9. PubMed ID: 16518941
[No Abstract] [Full Text] [Related]
3. Two amlodipine/ARB combinations for hypertension.
Med Lett Drugs Ther; 2007 Dec; 49(1276):101-2. PubMed ID: 18084152
[No Abstract] [Full Text] [Related]
4. [When after myocardial infarction a pump weakness remains. ACE inhibitors and AT-1 blockers equivalent].
MMW Fortschr Med; 2003 Dec; 145(49):18-9. PubMed ID: 14963986
[No Abstract] [Full Text] [Related]
5. Aliskiren/valsartan (Valturna) for hypertension.
Med Lett Drugs Ther; 2009 Nov; 51(1326):94-5. PubMed ID: 20224524
[No Abstract] [Full Text] [Related]
6. [Convincing results from the JIKEI Study].
MMW Fortschr Med; 2006 Dec; 148(51-52):55. PubMed ID: 17619349
[No Abstract] [Full Text] [Related]
7. Exforge HCT.
Med Lett Drugs Ther; 2009 Jun; 51(1314):47. PubMed ID: 19528888
[No Abstract] [Full Text] [Related]
8. [Preventing end-organ damage in hypertension. What is the significance of the VALUE Study for general practice?].
Zidek W
MMW Fortschr Med; 2004 Jul; 146(27-28):41. PubMed ID: 15526662
[No Abstract] [Full Text] [Related]
9. [New effective dosage of valsartan. High dosage--effective against high blood pressure].
MMW Fortschr Med; 2007 Nov; 149(46):52-3. PubMed ID: 18069195
[No Abstract] [Full Text] [Related]
10. Angiotensin receptor blockers and myocardial infarction.
Verma S; Strauss M
BMJ; 2004 Nov; 329(7477):1248-9. PubMed ID: 15564232
[No Abstract] [Full Text] [Related]
11. [Dilemma of antihypertensive therapy: high blood pressure diminishes, potency sometimes, too].
MMW Fortschr Med; 2006 Sep; 148(38):17. PubMed ID: 17036956
[No Abstract] [Full Text] [Related]
12. [Valsartan improves symptoms and quality of life in patients with chronic heart failure].
Baumhäkel M; Müller U; Böhm M
MMW Fortschr Med; 2008 Apr; 150 Suppl 1():48-53. PubMed ID: 18540333
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin receptor blockers and myocardial infarction: the importance of dosage.
Sarzani R; Dessì-Fulgheri P
J Hypertens; 2006 Aug; 24(8):1679-81; author reply 1681-2. PubMed ID: 16877973
[No Abstract] [Full Text] [Related]
14. [Fetal toxicity of angiotensin-II-receptor inhibitors. Case report].
Roger N; Popovic I; Madelenat P; Mahieu-Caputo D
Gynecol Obstet Fertil; 2007 Jun; 35(6):556-60. PubMed ID: 17544313
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic implications of high-dose angiotensin receptor blocker monotherapy in mild-to-moderate hypertensive patients.
Yano Y; Kario K
Hypertens Res; 2010 Oct; 33(10):981-3. PubMed ID: 20720555
[No Abstract] [Full Text] [Related]
16. Angiotensin receptor blockers: baseline therapy in hypertension?
Messerli FH; Bangalore S; Ruschitzka F
Eur Heart J; 2009 Oct; 30(20):2427-30. PubMed ID: 19723696
[No Abstract] [Full Text] [Related]
17. [Risk oriented therapy of hypertension. Lowering blood pressure and risk].
MMW Fortschr Med; 2007 Nov; 149(46):53. PubMed ID: 18069196
[No Abstract] [Full Text] [Related]
18. [AT1 receptor antagonists in treatment of hypertension].
Franz IW
Fortschr Med; 1997 Jul; 115(19):38-40. PubMed ID: 9333581
[No Abstract] [Full Text] [Related]
19. [First fixed combination of sartan and high-dosage diuretic. A strong duo against high blood pressure].
MMW Fortschr Med; 2004 Apr; 146(14):45. PubMed ID: 15344757
[No Abstract] [Full Text] [Related]
20. [VALISH].
Rakugi H; Ogihara T
Nihon Rinsho; 2006 Aug; 64 Suppl 6():454-8. PubMed ID: 16981579
[No Abstract] [Full Text] [Related]
[Next] [New Search]
